The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome

Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload of managing the disease has become overwhelming. This growing concern is known as the treatment burden of diabetes care, and clinicians are beginning to recognize it as a critical factor influencing adherence, glycemic control, healthcare utilization, and long-term outcomes.

Rather than asking only whether a therapy lowers A1C, providers are increasingly asking another important question: Can the patient realistically sustain this treatment over time? As healthcare shifts toward person-centered care, understanding and reducing the burden of diabetes treatment has become an essential component of high-quality diabetes management.

Table of Contents

• Understanding diabetes treatment burden
• Why treatment burden affects clinical outcomes
• Measuring treatment burden in routine practice
• Practical strategies for reducing the burden of care
• Conclusion
• Frequently Asked Questions

Understanding Diabetes Treatment Burden

The treatment burden associated with diabetes refers to the physical, emotional, financial, and logistical work required to manage diabetes and its therapies. Unlike diabetes distress, which focuses mainly on emotional responses, treatment burden includes the daily tasks patients must complete to stay healthy.

These responsibilities often include taking multiple medications, monitoring blood glucose, managing insulin dosing, maintaining dietary changes, attending medical appointments, navigating insurance requirements, and using diabetes technologies. For many patients, these demands occur alongside work, caregiving responsibilities, and other chronic conditions.

As treatment options expand, the complexity of care often increases. A patient may use a CGM, administer weekly injectable medication, monitor carbohydrate intake, refill prescriptions through multiple pharmacies, and communicate with several specialists. Although each intervention may offer clinical benefit, the combined workload can become difficult to sustain.

Research increasingly shows that when treatment demands exceed a patient’s capacity, adherence declines and health outcomes may worsen. This concept aligns with the cumulative complexity model, which recognizes that healthcare success depends not only on medical recommendations but also on the patient’s ability to carry them out.

The American Diabetes Association’s Standards of Care emphasize individualized treatment decisions that account for patient preferences, costs, and treatment complexity. Likewise, resources available through Healthcare.pro can help patients connect with healthcare professionals when diabetes management becomes increasingly difficult.

Why Diabetes Treatment Burden Influences Long-Term Outcomes

The impact of a high diabetes treatment burden extends well beyond convenience. Excessive treatment demands can contribute to medication nonadherence, missed appointments, poorer glycemic control, and lower quality of life.

Medication adherence illustrates this challenge clearly. Patients prescribed multiple daily medications with varying dosing schedules may experience confusion, fatigue, or intentional nonadherence. In addition, financial barriers can make adherence harder, especially when insulin, CGMs, and newer medications involve significant out-of-pocket costs despite insurance coverage.

Technology has also introduced new challenges. While CGMs and insulin pumps provide important clinical benefits, they require ongoing troubleshooting, software updates, supply management, and data interpretation. Some patients embrace these tools enthusiastically. However, others may experience technology fatigue or anxiety related to continuous monitoring.

Lifestyle interventions, although foundational to diabetes care, may also contribute to the overall care burden. Meal planning, exercise routines, frequent glucose checks, and dietary modifications require sustained attention every day. Over time, even highly motivated patients may experience burnout.

Importantly, treatment burden in diabetes may affect older adults, individuals with limited health literacy, lower-income populations, and patients managing multiple chronic conditions more intensely. Social determinants of health often magnify these challenges, making individualized treatment planning increasingly important.

Recognizing these realities helps clinicians move beyond viewing nonadherence as patient failure. Instead, poor adherence may signal that the treatment plan itself has become too complicated, costly, or disruptive for the patient’s daily life.

Measuring Treatment Burden During Diabetes Visits

Until recently, treatment burden was difficult to quantify during routine practice. Fortunately, several validated assessment tools now allow clinicians to identify patients experiencing excessive healthcare workload.

The Patient Experience with Treatment and Self-Management (PETS) questionnaire measures multiple dimensions of treatment burden, including medication management, financial stress, healthcare navigation, and self-monitoring responsibilities. Similarly, the Treatment Burden Questionnaire (TBQ) evaluates how healthcare demands affect daily functioning.

Although these instruments provide comprehensive assessment, even brief conversations can reveal valuable insights. Clinicians might ask which part of managing diabetes feels most difficult, whether medications are becoming difficult to afford, or whether the treatment routine interferes with work, family life, or sleep.

They may also ask whether patients have skipped treatments because the plan feels overwhelming. Another useful question is whether diabetes technology is helping or creating additional stress. These simple prompts can uncover barriers that laboratory values alone cannot show.

A patient with an acceptable A1C may still be struggling significantly to maintain the regimen. Therefore, integrating treatment burden assessment into routine diabetes visits supports shared decision-making and helps clinicians design more sustainable care plans.

Strategies for Reducing Diabetes Care Burden Without Sacrificing Quality

Reducing the overall burden of diabetes treatment does not necessarily require less intensive diabetes management. Instead, it focuses on simplifying care while preserving clinical effectiveness.

Medication simplification represents one of the most effective interventions. Fixed-dose combination therapies, once-weekly medications, and simplified insulin regimens can substantially reduce the daily workload. In some cases, deprescribing unnecessary medications may also improve adherence and patient satisfaction.

Technology should also be individualized. While advanced devices benefit many patients, others may achieve better outcomes with simpler approaches that match their preferences, skills, and daily routines.

Financial counseling can reduce cost-related barriers. Clinicians should routinely discuss affordability and consider lower-cost therapeutic alternatives when appropriate. In addition, connecting patients with assistance programs may improve access and adherence.

Care coordination also plays an important role. Streamlining appointments, improving communication between specialists, and reducing duplicate testing can lessen healthcare-related workload.

Perhaps most importantly, shared decision-making ensures that treatment plans reflect patient priorities rather than guideline recommendations alone. When patients participate actively in selecting therapies, they are more likely to sustain those treatments over time.

Many clinicians are also incorporating patient-reported outcome measures alongside traditional clinical metrics. This broader perspective allows healthcare teams to evaluate both biomedical success and treatment sustainability.

Conclusion

As diabetes care continues to evolve, clinicians must recognize that successful treatment extends beyond lowering blood glucose. The workload required to achieve those outcomes matters just as much.

Assessing and reducing treatment burden allows providers to create individualized care plans that patients can realistically maintain over the long term. By simplifying therapies, addressing financial barriers, personalizing technology use, and incorporating treatment burden into routine clinical assessment, healthcare professionals can improve adherence, enhance quality of life, and support better diabetes outcomes.

Future diabetes management will likely measure success not only by A1C and time in range, but also by whether patients can realistically sustain their care. Recognizing treatment burden as a meaningful clinical outcome represents an important step toward truly patient-centered diabetes care.

Frequently Asked Questions

What is the treatment burden of diabetes?

The treatment burden of diabetes includes the physical, emotional, financial, and practical work required to manage medications, glucose monitoring, lifestyle changes, and healthcare appointments.

How is treatment burden different from diabetes distress?

Treatment burden focuses on the workload of healthcare tasks, while diabetes distress primarily reflects the emotional impact of living with diabetes.

Can treatment burden affect blood glucose control?

Yes. A high care burden can lead to reduced medication adherence, missed appointments, and difficulty maintaining recommended self-care behaviors, all of which may affect glycemic control.

How can clinicians measure treatment burden?

Validated tools such as the Patient Experience with Treatment and Self-Management questionnaire and the Treatment Burden Questionnaire can help assess treatment workload during routine care.

What strategies help reduce diabetes treatment burden?

Simplifying medication regimens, individualizing technology use, addressing financial barriers, improving care coordination, and using shared decision-making can reduce treatment burden while maintaining effective diabetes management.

Disclaimer: This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.